ABC’s Stephanopoulos donating blood plasma in COVID-19 study

ABC anchor George Stephanopoulos will donate his blood plasma as part of a COVID-19 study, he announced Tuesday.

Stephanopoulos said Tuesday on “Good Morning America” that he had signed up for a clinical trial study where he will donate his blood plasma after tests showed he developed antibodies to fight the virus. 

These studies involving blood plasma aim to create new treatments for those infected with COVID-19 using antibodies from recovered patients. 

“So I’ve cleared the virus now. I’m fully recovered, and I hope to complete that blood plasma donation soon,” he said. “I’m looking forward to making that donation in the coming days and weeks.”  

.@GStephanopoulos announces he has signed up for a clinical trial to donate blood plasma and potentially help COVID-19 patients. pic.twitter.com/eCEqdqVVbV

— Good Morning America (@GMA) April 21, 2020

The 59-year-old ABC anchor, who hosts “Good Morning America” and “This Week,” tested positive for the virus last week, about two weeks after his wife, Ali Wentworth, announced her diagnosis on April 1.

Stephanopoulos has continued anchoring from home.

Blood donation companies, like Vitalant, began pilot programs earlier this month looking for donations from recovered COVID-19 patients for their research into possible treatments for the virus. 

It is unclear from his announcement what program Stephanopoulos is participating in.